Based on these previous literatures, we searched several online tools for candidate miRNAs that might target caspase 3 and/or caspase 8 to inhibit their expression in TRAIL-resistant hepatocellular carcinoma cell lines, HepG2R and Bel-7402R. This evidence concerns the gene CASP3 and hepatocellular carcinoma.